Arete Wealth Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,972
Closed -$450K 602
2023
Q2
$450K Buy
7,972
+655
+9% +$36.1K 0.04% 382
2023
Q1
$395K Sell
7,317
-2,377
-25% -$127K 0.03% 401
2022
Q4
$510M Buy
9,694
+481
+5% +$24.4K 0.04% 321
2022
Q3
$435K Sell
9,213
-245,364
-96% -$12.7M 0.04% 330
2022
Q2
$11M Buy
254,577
+246,972
+3,247% +$13.5M 1.12% 20
2022
Q1
$464K Sell
7,605
-3,084
-29% -$184K 0.04% 296
2021
Q4
$699K Sell
10,689
-67
-0.6% -$4.29K 0.06% 231
2021
Q3
$675K Buy
10,756
+1,096
+11% +$69.9K 0.07% 207
2021
Q2
$580K Sell
9,660
-1,488
-13% -$86.1K 0.08% 186
2021
Q1
$614K Buy
+11,148
New +$618K 0.08% 212

Other funds holding IHI

Arete Wealth Advisors's IHI Position: Q3 2023 in Review

Arete Wealth Advisors sold out of iShares US Medical Devices ETF (IHI) in Q3 2023, closing a stake of 7,972 shares — an estimated $450K sold.

Arete Wealth Advisors first reported a position in IHI in Q1 2021 and held it in 10 quarters. The position peaked at $510M in Q4 2022. 544 funds tracked by Wall St. Rank hold IHI as of Q3 2023.

  • Arete Wealth Advisors reported no remaining iShares US Medical Devices ETF position as of Q3 2023 after selling out during the quarter.
  • Arete Wealth Advisors sold 7,972 iShares US Medical Devices ETF shares in Q3 2023, an estimated $450K.
  • Arete Wealth Advisors first reported a position in iShares US Medical Devices ETF in Q1 2021 and held it in 10 quarters.
  • Arete Wealth Advisors's iShares US Medical Devices ETF position peaked at $510M in Q4 2022.
  • 544 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2023.

Based on Arete Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.